Norgine Overview
- Year Founded
-
1906
- Status
-
Private
- Employees
-
1,500
- Latest Deal Type
-
Debt Refin.
- Financing Rounds
-
6
- Investments
-
10
Norgine General Information
Description
Manufacturer of specialty pharmaceutical products focused on adding value and benefits to healthcare systems and patients. The company offers transformative medicines and operates third-party supply networks and significant product development capabilities as well as a sales and marketing infrastructure, thereby enabling clients to have access to quality products in a cost-effective manner.
Contact Information
Website
www.norgine.comCorporate Office
- Cross Towers, Antonio Vivaldistraat 150
- 1083 HP Amsterdam
- Netherlands
Corporate Office
- Cross Towers, Antonio Vivaldistraat 150
- 1083 HP Amsterdam
- Netherlands
Norgine Timeline
Norgine Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Norgine Comparisons
Industry
Financing
Details
Norgine Competitors (42)
One of Norgine’s 42 competitors is STADA Eurasia, a Corporation company based in Almaty, Kazakhstan.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| STADA Eurasia | Corporation | Almaty, Kazakhstan | ||||
| STADA Slovakia | Corporation | Bratislava, Slovakia | ||||
| Stada Croatia | Corporation | Zagreb, Croatia | ||||
| STADA Arzneimittel | Private Equity-Backed | Bad Vilbel, Germany | ||||
| STADA ANZ | Corporation | Sydney, Australia |
Norgine Patents
Norgine Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4613269-A1 | Rifaximin for use in treating sarcopenia in patients with liver disease | Inactive | 05-Mar-2024 | ||
| WO-2025186294-A1 | Rifaximin for use in treating sarcopenia in patients with liver disease | Pending | 05-Mar-2024 | ||
| WO-2025186294-A8 | Rifaximin for use in treating sarcopenia in patients with liver disease | Pending | 05-Mar-2024 | ||
| JP-2019172706-A | Method for washing colon | Active | 11-Jul-2019 | ||
| JP-2021152088-A | Methods for cleansing colon | Pending | 11-Jul-2019 |
Norgine Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Norgine Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Norgine Investments & Acquisitions (10)
Norgine’s most recent deal was a Buyout/LBO with Theravia for . The deal was made on 13-Aug-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Theravia | 13-Aug-2025 | Buyout/LBO | Drug Discovery | ||
| PathoQuest | 04-Apr-2023 | Later Stage VC | Biotechnology | ||
| Resolve Biosciences | 24-Oct-2022 | Early Stage VC | Other Pharmaceuticals and Biotechnology | ||
| Azanta | 24-Mar-2020 | Merger/Acquisition | Drug Discovery | ||
| Merus Labs International | 17-Jul-2017 | Merger/Acquisition | Other Healthcare Services |
Norgine Exits (2)
Norgine’s most recent exit was on 04-Apr-2023 from PathoQuest. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| PathoQuest | 04-Apr-2023 | Completed |
|
||
| Arc Medical Design | 01-Apr-2015 | Merger/Acquisition | Completed |
Norgine Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Theravia | Neuilly-Sur-Seine, France | 2002 |
Norgine FAQs
-
When was Norgine founded?
Norgine was founded in 1906.
-
Where is Norgine headquartered?
Norgine is headquartered in Amsterdam, Netherlands.
-
What is the size of Norgine?
Norgine has 1,500 total employees.
-
What industry is Norgine in?
Norgine’s primary industry is Pharmaceuticals.
-
Is Norgine a private or public company?
Norgine is a Private company.
-
What is Norgine’s current revenue?
The current revenue for Norgine is .
-
How much funding has Norgine raised over time?
Norgine has raised $1.02B.
-
Who are Norgine’s investors?
Goldman Sachs Asset Management has invested in Norgine.
-
Who are Norgine’s competitors?
STADA Eurasia, STADA Slovakia, Stada Croatia, STADA Arzneimittel, and STADA ANZ are some of the 42 competitors of Norgine.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
